Showing results (41-50 of 104) with videos related to

Sort By:
Pageof 11
Journal of the International AIDS Society|November 1, 2023
Change in HIV-related characteristics of children hospitalised with infectious diseases in Western Cape, South Africa, 2008-2021: a time trend analysisShani T de Beer, Amy L Slogrove, Brian Eley, et al.
Cancer Chemotherapy and Pharmacology|December 20, 2011
Tolerability and pharmacokinetic profile of a sunitinib powder formulation in pediatric patients with refractory solid tumors: a Children's Oncology Group studySteven G DuBois, Suzanne Shusterman, Joel M Reid, et al.
Pediatric Blood & Cancer|January 6, 2010
Phase I trial of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with relapsed or refractory solid tumors: a Children's Oncology Group phase I consortium studyLars M Wagner, John P Perentesis, Joel M Reid, et al.
Microbiology Spectrum|November 10, 2021
Prospective Study of the Performance of Parent-Collected Nasal and Saliva Swab Samples, Compared with Nurse-Collected Swab Samples, for the Molecular Detection of Respiratory MicroorganismsClaire A Woodall, Hannah V Thornton, Emma C Anderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2008
Pediatric phase I and pharmacokinetic study of erlotinib followed by the combination of erlotinib and temozolomide: a Children's Oncology Group Phase I Consortium StudyRegina I Jakacki, Marta Hamilton, Richard J Gilbertson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2013
A phase I trial of imetelstat in children with refractory or recurrent solid tumors: a Children's Oncology Group Phase I Consortium Study (ADVL1112)Patrick A Thompson, Rachid Drissi, Jodi A Muscal, et al.
AIDS (London, England)|December 12, 2025
Infectious-cause hospitalisation in a province-wide cohort of children with antenatal HIV exposure compared to children without HIV exposureShani T de Beer, Florence Phelanyane, Suzanne M Ingle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2007
A phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory leukemia: a Children's Oncology Group studyTerzah M Horton, Debananda Pati, Sharon E Plon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 11, 2012
A phase I trial and pharmacokinetic study of sorafenib in children with refractory solid tumors or leukemias: a Children's Oncology Group Phase I Consortium reportBrigitte C Widemann, Aerang Kim, Elizabeth Fox, et al.
Pediatric Blood & Cancer|April 5, 2013
A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: a Children's Oncology Group phase 1 consortium studyTrent R Hummel, Lars Wagner, Charlotte Ahern, et al.
Pageof 11